The Clinical Neuroscience and Neuroimaging Lab (PI: Dr. Hengyi Cao) in the Institute of Behavioral Science (IBS), Feinstein Institutes for Medical Research is seeking a highly motivated postdoctoral associate for a recently funded NIH R01 project. We use multimodal imaging (structural, functional, diffusional MRI) and neuromodulation (TMS) approaches to study the cognitive function of the cerebellum and its mechanisms for the onset and treatment of psychotic disorders. The funded project will be focused on the development of the cerebellum and the training of cerebellum-based predictive models for psychosis prediction.

 

We welcome applicants who are interested in psychosis and/or cerebellar neuroscience, with strong skills in neuroimaging data analysis, statistics, and machine learning. Previous experience in neurodevelopment is a plus. The successful applicant will be focusing on analyzing a large array of existing datasets, writing up papers, and publishing in high-impact journals. The applicant will also have opportunity to contribute to other ongoing projects in the institute as well as to develop independent studies and acquire independent fundings. The IBS is located at the Zucker Hillside Hospital, one of the largest psychiatric facilities in the broader New York area. It has been an NIH-funded Advanced Center for Intervention and Services Research on Early Psychosis for approximately thirty consecutive years and has tremendous clinical and research resources for conducting various psychiatric studies.

 

To apply, please send a cover letter describing your research interest and prior experience, a CV, and contact information of three references to Hengyi Cao (hcao2@northwell.edu). We provide competitive salary commensurate with living costs in the New York City. The position can start as early as January 2025 and will be evaluated on a rolling basis until filled.

 

The information contained in this electronic e-mail transmission and any attachments are intended only for the use of the individual or entity to whom or to which it is addressed, and may contain information that is privileged, confidential and exempt from disclosure under applicable law. If the reader of this communication is not the intended recipient, or the employee or agent responsible for delivering this communication to the intended recipient, you are hereby notified that any dissemination, distribution, copying or disclosure of this communication and any attachment is strictly prohibited. If you have received this transmission in error, please notify the sender immediately by telephone and electronic mail, and delete the original communication and any attachment from any computer, server or other electronic recording or storage device or medium. Receipt by anyone other than the intended recipient is not a waiver of any attorney-client, physician-patient or other privilege.